Does RISANKIZUMAB-RZAA Cause Device issue? 1,245 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,245 reports of Device issue have been filed in association with RISANKIZUMAB-RZAA. This represents 1.9% of all adverse event reports for RISANKIZUMAB-RZAA.
1,245
Reports of Device issue with RISANKIZUMAB-RZAA
1.9%
of all RISANKIZUMAB-RZAA reports
1
Deaths
168
Hospitalizations
How Dangerous Is Device issue From RISANKIZUMAB-RZAA?
Of the 1,245 reports, 1 (0.1%) resulted in death, 168 (13.5%) required hospitalization.
Is Device issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 1,245 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Device issue?
ADALIMUMAB (17,630)
SOMATROPIN (5,131)
PEGFILGRASTIM (5,071)
ETANERCEPT (4,143)
INSULIN GLARGINE (3,175)
EXENATIDE (2,862)
LEVONORGESTREL (2,623)
CARBIDOPA\LEVODOPA (2,574)
GOLIMUMAB (1,827)
USTEKINUMAB (1,716)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Device issue Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA